Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by a shared purpose: to partner with professionals to improve lives. We help our customers deliver the best possible patient care through industry-leading products, solutions, and technology. Our comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers a wide range of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the human smile. We further support the dental community with leading solutions in restoratives, endodontics, rotary, infection prevention, and loupes. We were formed in 2018 as a wholly-owned subsidiary of Danaher Corporation. In 2019, we completed our initial public offering and separated from Danaher Corporation.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 2.7B | 2.7B | 2.5B | 2.6B | 2.6B | 2.5B |
| Net Income | 47M | 47M | -1.1B | -100M | 243M | 341M |
| EPS | $0.28 | $0.28 | $-6.50 | $-0.60 | $1.37 | $1.92 |
| Free Cash Flow | 230M | 230M | 303M | 218M | 107M | 307M |
| ROIC | 1.7% | 3.9% | -22.9% | 0.6% | 5.2% | 6.0% |
| Gross Margin | 54.7% | 54.7% | 54.7% | 56.1% | 57.4% | 56.9% |
| Debt/Equity | 0.47 | 0.47 | 0.51 | 0.39 | 0.45 | 0.43 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | 216M | 216M | -1.0B | 32M | 319M | 306M |
| Operating Margin | 7.9% | 7.9% | -41.4% | 1.2% | 12.4% | 12.2% |
| ROE | 1.5% | 1.6% | -31.5% | -2.4% | 5.9% | 8.8% |
| Shares Outstanding | 168M | 168M | 172M | 167M | 177M | 177M |
Envista Holdings Corp passes 5 of 9 quality checks, suggesting mixed fundamentals.
Envista Holdings Corp trades at 97.8x trailing earnings, compared to its 15-year median P/E of 23.8x, suggesting it is currently Expensive relative to its historical range. On a free-cash-flow basis, the stock trades at 19.5x vs a median of 18.7x. The company's 5-year average gross margin is 55.9%. Total shareholder yield (buybacks) is 3.6%. At current prices, the estimated annualized return to fair value is -6.0%.
Envista Holdings Corp (NVST) has a current P/E ratio of 97.8, compared to its historical median P/E of 23.8. The stock is currently considered Expensive based on its historical valuation range.
Envista Holdings Corp (NVST) has a 5-year average return on invested capital (ROIC) of -1.4%. This is below average and may indicate limited pricing power.
Envista Holdings Corp (NVST) has a market capitalization of $4.6B. It is classified as a mid-cap stock.
Envista Holdings Corp (NVST) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 3.62%.
Based on historical P/E analysis, Envista Holdings Corp (NVST) appears expensive. The current P/E of 97.8 is 310% above its historical median of 23.8. The estimated fair value CAGR (P/E method) is -13.9%.
Envista Holdings Corp (NVST) operates in the Dental Equipment & Supplies industry, within the Healthcare sector.
Envista Holdings Corp (NVST) reported annual revenue of $2.7 billion in its most recent fiscal year, based on SEC EDGAR filings.
Envista Holdings Corp (NVST) has a net profit margin of 1.7%. This is a modest margin.
Envista Holdings Corp (NVST) generated $230 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
Envista Holdings Corp (NVST) has a debt-to-equity ratio of 0.47. This indicates a conservatively financed balance sheet.
Envista Holdings Corp (NVST) reported earnings per share (EPS) of $0.28 in its most recent fiscal year.
Envista Holdings Corp (NVST) has a return on equity (ROE) of 1.6%. This indicates moderate shareholder returns.
Envista Holdings Corp (NVST) has a 5-year average gross margin of 55.9%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 9 years of financial data for Envista Holdings Corp (NVST), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Envista Holdings Corp (NVST) has a book value per share of $18.51, based on its most recent annual SEC filing.
No recent press releases.